Trimetazidine does not modify blood levels and immunosuppressant effects of cyclosporine A in renal allograft recipients

Aims In renal allograft recipients, trimetazidine (Vastarel(®) ) was proposed to be associated with the classic immunosuppressant treatments because it displays anti-ischaemic effects which may protect against cyclosporine A nephrotoxicity. The objective of this work was to assess the possibility of...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Simon, Nicolas, Brunet, Philippe, Roumenov, Dimitri, Dussol, Bertrand, Barre, Jerome, Duche, Jean-Claude, Albengres, Edith, D’Athis, Philippe, Chauvet-Monges, Anne-Marie, Berland, Yvon, Tillement, Jean-Paul
Format: Artigo
Sprache:Inglês
Veröffentlicht: 1997
Schlagworte:
Original Articles
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC2042879/
https://ncbi.nlm.nih.gov/pubmed/9431838
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1046/j.1365-2125.1997.t01-1-00628.x
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge